Europe

  • Butterfly Medical secures US$21m to advance minimally invasive BPH treatment

    Butterfly Medical, developer of a proprietary non-surgical solution for BPH (benign prostatic hyperplasia), today announced the successful completion of its Series C funding round, raising US$21 million. The strong institutional demand validates the company’s therapeutic approach and competitive positioning. The round includes participation from new and existing investors, including the European Innovation Council (EIC), Junson [...]

  • ‘Highly concerning’ poll reveals one in seven preferring AI to seeing a doctor

    One in seven people are using AI chatbots for health advice instead of seeing their GP, a UK poll has found. Doctors said the findings were “highly concerning” and warned that patients could be put at risk if they rely on chatbots rather than trained professionals. The study analysed responses from more than [...]

  • WWL embeds national clinical guidance into Altera Digital Health’s Sunrise EPR to transform Acute Abdomen Pathway

    Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust (WWL) and Altera Digital Health have unveiled the results of a digital transformation that has optimised the Acute Abdomen Pathway. By embedding National Emergency Laparotomy Audit (NELA) guidance into WWL's Altera Sunrise Electronic Patient Record (EPR) platform, the trust has achieved significant improvements in patient outcomes, [...]

  • Living ‘tumour on a chip’ could offer new brain cancer insights

    A living 'tumour-on-chip' is being developed to study glioblastoma and how drugs might best reach the aggressive brain cancer. The system is designed to mimic key features of the human brain inside a small laboratory device. Researchers hope it could offer fresh insight into how glioblastoma tumours grow and provide a more human-relevant way to [...]

  • Infinitopes appoints immuno-oncology pioneer Jo Brewer as CSO

    Infinitopes, a biotechnology company developing novel and precision immunotherapy, has announced the appointment of Jo Brewer, PhD, as chief scientific officer and interim chief operating officer. Dr Brewer, a pioneer and recognised industry leader in cancer immunotherapy and cell therapies, has served as a non-executive director (NED) of the company since March 2025, now joining [...]

  • Isomorphic Labs raises $2.1bn Series B to scale AI-driven drug discovery

    Isomorphic Labs has raised US$2.1bn to scale its AI drug discovery engine, expand globally and progress its drug candidate pipeline towards the clinic. Isomorphic Labs said the new capital will be used to continue developing and deploying its AI drug design engine, known as IsoDDE. The company says the platform is designed to [...]

  • Digital health startup Ditto raises €7.6 million

    Ditto has raised €7.6m to expand across Europe with its free app that translates complex medical information into plain language. The Rotterdam-based health tech startup has developed an app designed to help patients and their families make sense of what was said in a medical consultation. Ditto was founded in 2024 by Tobias [...]

  • MPs sound alarm over NHS patient data deal with Palantir

    MPs have warned the NHS decision to widen Palantir data access is dangerous and could deepen public fears that patient privacy is not being prioritised. NHS England has allowed staff from the US technology firm and other contractors to access patient data before it has been pseudonymised, despite internal fears of a “risk of loss [...]

  • Royal Cornwall Hospitals NHS Trust launches major new programme for preventive care

    Royal Cornwall Hospitals NHS Trust (RCHT) has begun using a new digital tool to help find people who may be at risk of liver disease, potentially before symptoms appear. The system, called hepatoSIGHT, is now being used by NHS doctors at RCHT to support preventative care and earlier diagnosis. It works by securely analysing patterns [...]

  • Propel West Yorkshire launches second cohort of innovators at Nexus in Leeds

    Propel Healthtech West Yorkshire has launched its second cohort of innovators, bringing together founders, partners and stakeholders from across the region’s health innovation ecosystem. The launch event, held on Thursday 30 April 2026 at Nexus in Leeds, marks the continued growth of the programme following £4.5 million of investment secured in 2025 from the West [...]